Search results
Results from the WOW.Com Content Network
Pages in category "Life sciences industry" The following 200 pages are in this category, out of approximately 255 total. This list may not reflect recent changes .
As of 2019, twelve of top 20 biopharmaceutical companies in the world has U.S. headquarters in the state. [9] [10] Below is a list of notable New York metropolitan area biotechnology and pharmaceutical corporations, including companies with either global or U.S. headquarters in the metropolitan region encompassing and surrounding New York City.
Abstracts & full text ( 7.5 million) biomedical and life sciences articles (Dec 2020). Includes text mining tools and links to external molecular and medical data sets. Free Yes EMBL-EBI: PubMed Central (PMC) [13] Biomedical, life sciences: 7,500,000 Free full-text archive of publications and preprints Free Yes NIH, NLM: ResearchGate ...
Pages in category "Biotechnology companies of the United States" The following 200 pages are in this category, out of approximately 331 total. This list may not reflect recent changes .
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Download as PDF; Printable version; ... Life sciences industry (9 C, 255 P) Pages in category "Life sciences"
Another major branch of life sciences involves understanding the mind – neuroscience. Life sciences discoveries are helpful in improving the quality and standard of life and have applications in health, agriculture, medicine, and the pharmaceutical and food science industries. For example, it has provided information on certain diseases which ...
This BD business had annualized revenue of approximately $100 million; as of October 16, 2018, it had been integrated into Thermo Fisher's Life Sciences Solutions Segment. [43] In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio.